Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentAsset Writedowns and ImpairmentCash from Financing ActivitiesCash from Financing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesChange in TaxesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Free Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresLong-Term Debt IssuancesNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares IssuedShort-Term Debt issuancesShort-Term Debt repayments
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Dna X (SONM) Asset Writedowns and Impairment (2018 - 2025)

Dna X filings provide 7 years of Asset Writedowns and Impairment readings, the most recent being $984000.0 for Q4 2025.

  • On a quarterly basis, Asset Writedowns and Impairment fell 82.01% to $984000.0 in Q4 2025 year-over-year; TTM through Dec 2025 was $7.5 million, a 16.22% increase, with the full-year FY2025 number at $2.1 million, down 68.11% from a year prior.
  • Asset Writedowns and Impairment hit $984000.0 in Q4 2025 for Dna X, down from $1.1 million in the prior quarter.
  • In the past five years, Asset Writedowns and Impairment ranged from a high of $5.5 million in Q4 2024 to a low of -$2.2 million in Q3 2024.
  • Median Asset Writedowns and Impairment over the past 4 years was $730000.0 (2021), compared with a mean of $1.1 million.
  • Biggest five-year swings in Asset Writedowns and Impairment: skyrocketed 1300.0% in 2021 and later crashed 98.35% in 2022.
  • Dna X's Asset Writedowns and Impairment stood at $182000.0 in 2021, then crashed by 98.35% to $3000.0 in 2022, then surged by 182266.67% to $5.5 million in 2024, then plummeted by 82.01% to $984000.0 in 2025.
  • The last three reported values for Asset Writedowns and Impairment were $984000.0 (Q4 2025), $1.1 million (Q2 2025), and $5.5 million (Q4 2024) per Business Quant data.